LBPMedicine(SH:688393) Zheng Quan Zhi Xing·2025-08-21 10:22Core Viewpoint - The company plans to temporarily lease out part of the idle space from its marketing service network upgrade project to improve operational efficiency and generate additional revenue, pending approval from the shareholders' meeting [1][3]. Group 1: Fundraising Overview - The company raised a total of 713.27 million yuan from its initial public offering (IPO) by issuing 23.34 million shares at a price of 30.56 yuan per share, with a net amount of 639.95 million yuan after deducting issuance costs of 73.32 million yuan [1][2]. - The funds raised have been fully received and verified by Zhonghui Certified Public Accountants [2]. Group 2: Fund Utilization - The fundraising plan includes a project focused on the application development of a tumor companion diagnostic technology platform, with a total investment of 491.65 million yuan allocated for this purpose [2]. - The marketing service network upgrade project has been completed and is now in use, but due to a slowdown in domestic economic growth and increased competition, some space has become temporarily idle [2][3]. Group 3: Impact of Temporary Adjustment - The decision to lease out the idle space is based on the company's current operational needs and is not expected to adversely affect normal operations or harm shareholder interests [3][4]. - This adjustment is in compliance with relevant regulations and is aimed at enhancing the efficiency of the space and stabilizing the company's operations [3][4][5]. Group 4: Review Procedures - The board of directors and the supervisory board have both approved the proposal to lease the idle space, confirming that it aligns with the company's actual situation and does not harm shareholder interests [4][5]. - The sponsor institution has also reviewed the matter and found it compliant with regulatory requirements, supporting the decision to temporarily adjust the use of the idle space [4][5].